Key result
Cardiac magnetic resonance imaging overcomes limitations of echocardiography in assessing disease severity and myocardial remodeling in patients with valvular heart disease.
Why the study?
CMR can overcome limitations of echocardiography in assessing valvular heart disease and regurgitant lesions, motivating a review of its role in assessing disease severity and myocardial remodeling.
Does cardiac magnetic resonance (CMR) improve the assessment of disease severity and myocardial remodeling in patients with valvular heart disease?
Population
Patients with valvular heart disease
Design
Review
Authors
Loading...
Supports CMR evaluation in valvular disease where echo is limited; leaves open need for prospective outcome trials before practice change.
Does cardiac magnetic resonance (CMR) improve the assessment of disease severity and myocardial remodeling in patients with valvular heart disease?
CMR is a valuable imaging modality for assessing disease severity and myocardial remodeling in valvular heart disease, particularly for overcoming limitations of echocardiography in regurgitant lesions.
Malahfji et al. (2020) conducted a review in Valvular heart disease. Cardiac magnetic resonance (CMR) imaging vs. Echocardiography was evaluated. Cardiac magnetic resonance imaging overcomes limitations of echocardiography in assessing disease severity and myocardial remodeling in patients with valvular heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: